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Mutations in C8orf37, Encoding a Ciliary Protein,
are Associated with Autosomal-Recessive Retinal
Dystrophies with Early Macular Involvement
Alejandro Estrada-Cuzcano,1,2,3,12 Kornelia Neveling,1,3,12 Susanne Kohl,4 Eyal Banin,5
Ygal Rotenstreich,6 Dror Sharon,5 Tzipora C. Falik-Zaccai,7,8 Stephanie Hipp,9 Ronald Roepman,1,2,3
Bernd Wissinger,4 Stef J.F. Letteboer,1,2 Dorus A. Mans,1,2 Ellen A.W. Blokland,1 Michael P. Kwint,1,3
Sabine J. Gijsen,1,3 Ramon A.C. van Huet,10 Rob W.J. Collin,1,2,10 H. Scheffer,1,3 Joris A. Veltman,1,2,3
Eberhart Zrenner,9 the European Retinal Disease Consortium,11 Anneke I. den Hollander,1,2,3,10
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Cone-rod dystrophy (CRD) and retinitis pigmentosa (RP) are clinically and genetically overlapping heterogeneous retinal dystrophies.
By using homozygosity mapping in an individual with autosomal-recessive (ar) RP from a consanguineous family, we identified three
sizeable homozygous regions, together encompassing 46 Mb. Next-generation sequencing of all exons, flanking intron sequences,
microRNAs, and other highly conserved genomic elements in these three regions revealed a homozygous nonsense mutation
(c.497T>A [p.Leu166*]) in C8orf37, located on chromosome 8q22.1. This mutation was not present in 150 ethnically matched control
individuals, single-nucleotide polymorphism databases, or the 1000 Genomes database. Immunohistochemical studies revealed
C8orf37 localization at the base of the primary cilium of human retinal pigment epithelium cells and at the base of connecting cilia
of mouse photoreceptors. C8orf37 sequence analysis of individuals who had retinal dystrophy and carried conspicuously large homo-
zygous regions encompassing C8orf37 revealed a homozygous splice-site mutation (c.1562A>G) in two siblings of a consanguineous
family and homozygous missense mutations (c.529C>T [p.Arg177Trp]; c.545A>G [p.Gln182Arg]) in siblings of two other consanguin-
eous families. The missense mutations affect highly conserved amino acids, and in silico analyses predicted that both variants are
probably pathogenic. Clinical assessment revealed CRD in four individuals and RP with early macular involvement in two individuals.
The two CRD siblings with the c.1562A>Gmutation also showed unilateral postaxial polydactyly. These results underline the impor-
tance of disrupted ciliary processes in the pathogenesis of retinal dystrophies.Retinitis pigmentosa (RP [MIM 268000]) is the most
common inherited retinal degeneration and has an esti-
mated worldwide prevalence of 1/4,000 individuals.1
RP is initially characterized by rod photoreceptor dysfunc-
tion, giving rise to night blindness, which is followed by
progressive rod and cone photoreceptor dystrophy,
resulting in midperipheral vision loss, tunnel vision,
and sometimes blindness. The disease is genetically
highly heterogeneous and displays all Mendelian pat-
terns of inheritance. In addition, there are some cases
with mitochondrial mutations and digenic inheri-
tance.2,3 Thus far, mutations in 34 genes have been asso-
ciated with nonsyndromic autosomal-recessive (ar) RP
(RetNet).3
In contrast to RP, cone-rod dystrophy (CRD [MIM
120970]) is characterized by a primary loss of cone photo-
receptors and subsequent or simultaneous loss of rod
photoreceptors.4,5 The disease in most cases becomes
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without nystagmus, color-vision defects, and decreased
sensitivity of the central visual field. Because rods are also
involved, night blindness and peripheral vision loss can
occur. The diagnosis of CRD is mainly based on electro-
retinogram (ERG) recordings, in which cone (photopic)
responses are more severely reduced than, or equally as
reduced as, rod (scotopic) responses.5,6 CRD occurs in 1/
40,000 individuals4,5 and also displays all types of Mende-
lian inheritance. Mutations in five genes i.e., ABCA4 (MIM
601691), ADAM9 (MIM 602713), CDHR1 (MIM 609502),
CERKL (MIM 608381), and RPGRIP1 (MIM 605446) have
thus far been implicated in nonsyndromic arCRD.7–11
Genes harboring arCRD- and arRP-associated mutations
encode proteins that are involved in phototransduction,
vitamin A (retinoid) metabolism, transport along the con-
necting cilium, cell-to-cell signaling or synaptic interac-
tion, gene regulation, and phagocytosis.3 Mutations in
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Figure 1. Pedigrees with C8orf37 Mutations and Partial Align-
ment of C8orf37 Orthologs
(A) Schematic representation of the four consanguineous families
in which homozygous C8orf37 variants were identified. The
respective mutations (M1–M4) are indicated above the pedigrees.
In family 1, a protein-truncating mutation (p.Leu166*) was identi-
fied; in family 2, the c.1562A>G variant affects one of the canon-
ical nucleotides of a splice-acceptor site. Affected individuals in
families 3 and 4 carry C8orf37missense mutations that are located
in close proximity (see B). Theþ symbol represents wild-type. Dia-
mond-shaped symbols representmale(s) or female(s); the numbers
in the symbols indicate the numbers of individuals. Blackened
symbols represent affected individuals. Symbols with slashes
depict deceased individuals.
(B) Evolutionary conservation of the part of the C8orf37 polypep-
tide that contains the missense mutations p.Arg177Trp and
p.Gln182Arg, which are identified in families 3 and 4, respectively.
The alignment was performed via ClustalW2 with the following
protein sequences: human (NP_808880.1), rat (NP_001007747.1),
mouse (NP_680281.3), chicken (Xp_418346.2), frog
(XP_002931575.1), sea urchin (XP_001194284), Phytophtora
(XP_002904228.1), and Chlamydomonas (XP_001697126.1).
Amino acid residues that are identical in all sequences are white
on a black background, whereas amino acids that are similar
but not identical are black on a light gray background. Nonconser-
vative changes are indicated in black on a white background.
The AmericWe aimed to identify the genetic defects associated with
retinal dystrophies and to clinically investigate individuals
with RP and CRD. The tenets of the Declaration of Helsinki
were followed, and, in accordance with approvals gathered
from the appropriate institutional review boards, informed
consent was obtained from all participating individuals
prior to the donation of blood samples.
Homozygosity mapping has proven to be a fruitful
method of identifying mutations underlying autosomal-
recessive retinal diseases12–16 and of establishing geno-
type-phenotype correlations.17,18 To identify the genetic
defect in a consanguineous family with RP (family 1;
Figure 1A), we analyzed the DNA of individual IV:1
by using an Affymetrix GeneChip Human Mapping
250K SNP array (Affymetrix, Santa Clara, CA, USA)
and analyzed the SNP data by using Partek Genomic Suite
software (Partek, St. Louis, MO, USA). The analyses
showed three large homozygous regions of 7.7 Mb
(4q34.3-q35.1, rs2128423–rs59156350), 31.6 Mb (8q22.1-
q24.13, rs279475–rs7013593), and 7.0 Mb (11p11.2-q11,
rs11039487–rs17494990). Because more than 261 genes
werepresent in these three chromosomal regions, a targeted
next-generation sequencing (NGS) approach was used.
Sequence capture was done on a 385K sequence-capture
array (Roche NimbleGen, Madison, WI, USA). The array
design comprised all coding and noncoding exons of these
regions, including surrounding sequences that covered the
splice sites. The array design harbored additional targeted
regions used for similar analyses of homozygous regions
in two other families. In total, the design included 4,952
targets, comprising 1,903,789 bp. Sequence capture was
done according to themanufacturer’s (RocheNimbleGen’s)
instructions with the Titanium optimized protocol as
described by Hoischen et al.19 The enriched DNA regions
of individual IV:1 from family 1 were sequenced on one
of four lanes of a Roche 454 sequencing run, yielding
86 Mb of sequence data. Approximately 86% of the
sequences were mapped back to unique regions of the
human genome (hg18, NCBI build 36.1) with the use of
the Roche Newbler software (version 2.3). Of all mapped
reads, 91% were located on or near the targeted regions
(i.e., within 500 bp). This was sufficient to reach an
average of 19.3-fold coverage for all target regions. For
the regions of interest, fewer than 2.6% of all targeted
sequences were not covered, and only 22% of the target
sequence was covered fewer than ten times. The Roche
454 software detected a total of 2,755 high-confidence
variants, i.e., it identified the variants in at least three
reads. We used a custom-made data-analysis pipeline as
described elsewhere19 to annotate detected variants with
various types of information, including known SNPs,
amino acid substitutions, genomic location, and evolu-
tionary conservation. A total of 2,573 variants either were
found to represent known SNPs or overlapped with
a known polymorphic region (dbSNP129); they were
therefore not considered to be likely disease-causing
variants.an Journal of Human Genetics 90, 102–109, January 13, 2012 103
Figure 2. Homozygous Region in Individual IV:1 of Family 1, C8orf37 Exon-Intron Structure, and Sequence Variant
(A) The 31.6 Mb homozygous region encompassing the flanking SNPs and C8orf37 on part of chromosome 8q in IV:1 of family 1.
(B) Genomic structure of C8orf37, which consists of six exons, all of which are protein coding.
(C) Next-generation sequence traces for the reads covering the C8orf37 c.497T>A variant (minus strand), which results in a premature
stop codon (p.Leu166*). Twenty five reads, all of which show the c.497T>A change (visible in antisense direction as c.497A>T), encom-
pass cDNA nucleotide 497. The visibility of this mutation is hampered in the five reads at the bottom, probably because of the
mononucleotide stretches around the mutation. These stretches most likely lead to either sequencing or mapping problems when
the Roche 454 sequencing technology is used. The homozygosity of this variant was confirmed by traditional Sanger sequencing
(see D). The abbreviation wt represents the wild-type anti-sense sequence.
(D) Sanger sequencing confirmation of the c.497T>A variant in individual IV:1 of family 1.The remaining 182 variants included 39 nongenic
variants, 32 untranslated-region variants, 74 intronic
variants, two potential splice-site variants, and 35 exonic
variants. The exonic variants consisted of three synony-
mous coding variants and 32 nonsynonymous coding
variants. Of the latter 32 variants, only two were called
as homozygous variants (i.e.,>80% variant reads), whereas
the remaining 30 variants appeared heterozygous. The
finding of heterozygous variants in homozygous regions
can possibly be explained by the existence of pseudogenes
that are changing the ratio of variant reads to reference
reads.20
The two homozygous nonsynonymous variants
(c.2483T>C in C4orf41 [NM_199053.1] and c.497T>A
in C8orf37 [NM_177965.2]) were chosen for further
candidate analysis. SIFT predicted that the c.2483T>C
(p.Val828Ala) variant in C4orf41 would be tolerated, and
PolyPhen predicted that it would be benign. In addition,
this variant was found in the 1000 Genomes database
and in a heterozygous state in 3 out of 133 individuals,
who were analyzed via exome NGS. On the basis of the
latter finding, this variant would be present in a homozy-
gous state in ~1/8,000 individuals, a ratio that is 2 orders
of magnitude higher than that of other RP-associated vari-104 The American Journal of Human Genetics 90, 102–109, January 1ants. Together, these data strongly suggest that the C4orf41
variant is not associated with RP in family 1. The second
candidate variant was a homozygous c.497T>A variant in
C8orf37 in the 31.6 Mb region of 8q22.1 (Figures 2A and
2B) and resulted in a premature stop codon (p.Leu166*)
(Figures 2C and 2D). Sanger sequencing confirmed the
homozygous presence of this variant in IV:1 (Figure 2D)
and its presence as a heterozygous change in both parents
(Figure 1A). This mutation was not detected in 300 chro-
mosomes of ethnically matched control individuals or in
the 1000 Genomes database.
C8orf37 spans 23,203 nucleotides of genomic DNA
and consists of six exons that encode a polypeptide that
is 207 amino acids long (Figure 2B). The function of
C8orf37 is unknown, and because it lacks known func-
tional protein domains, it is difficult to predict its role in
the retina. In adult human tissues, C8orf37 is expressed
ubiquitously and there are high levels of mRNA expression
in the brain, heart, and retinae (Figure 3A). Immunohisto-
chemical studies on hTERT-RPE1 cells with anti-C8orf37
(rabbit polyclonal, Sigma-Aldrich, MO, USA), which was
tested for specificity in cow retinal extracts (Figure S1,
available online), suggested that C8orf37 is localized
in the cytoplasm (data not shown). However, after cilia3, 2012
Figure 3. mRNA and Protein-Expression Characteristics of
C8orf37
(A) mRNA expression of C8orf37 in adult human tissues is the
highest in the heart and the brain, followed by the retinae. The
y axis shows the relative expression of C8orf37 in comparison to
the lowest expression detected in the liver. For liver expression,
the DDCt value was set at 0, resulting in an arbitrary expression
of 1.33,34 The x axis shows the adult human tissues that were
tested for C8orf37 expression.
(B–D) Immunohistochemical staining of ciliated hTERT-RPE1
cells with antibodies against human C8orf37 (in green), and (in
The Americformation was induced with serum starvation,21 C8orf37
was localized at the base of the primary cilium, as indicated
by partial colocalization with polyglutamylated tubulin
antibody GT335 (mouse monoclonal, Abcam, Cambridge,
UK), a ciliary marker (Figure 3B). Similar results were
observed when the ciliary marker antiacetylated a-tubulin
(mouse monoclonal, Sigma-Aldrich, MO, USA) and anti-
g-tubulin (mouse monoclonal, Sigma-Aldrich, MO, USA)
were used in combination with anti-C8orf37 (Figures 3C
and 3D). Immunolocalization studies with the same
antibodies in postnatal day 30 mouse retinal sections
(Figures 3E–3G) also revealed an intense C8orf37 staining
at the base of the photoreceptor connecting cilia. In addi-
tion, staining was observed in the photoreceptor inner
segments; this staining possibly represents the rootlets.
To determine whether mutations in C8orf37 are more
widely involved in retinal dystrophies, we assessed ~400
unrelated individuals who had arCRD, arRP, or Leber
congenital amaurosis (LCA [MIM 204000]) and who had
significant homozygous regions, i.e., >2 Mb for individ-
uals in nonconsanguineous families and >4 Mb for
individuals in consanguineous families.13,14,16,20,22 In 15
consanguineous families and in none of the nonconsan-
guineous families, C8orf37 was located in conspicuously
large homozygous regions, and sequence analysis of the
C8orf37 coding exons revealed DNA variants in three addi-
tional consanguineous families (Figure 1A). Two affected
siblings in family 2 carried a homozygous splice-site muta-
tion (c.1562A>G), whereas in families 3 and 4, all
affected siblings carried the missense mutations
p.Arg177Trp (c.529C>T) and p.Gln182Arg (c.545A>G),
respectively. When available, additional affected and unaf-
fected family members were analyzed, revealing that in
each family, mutations fully cosegregated with the disease
if one assumed an autosomal-recessive mode of inheri-
tance (Figure 1A). The c.1562A>G and c.529C>T vari-
ants were not found in 179 ethnically matched control
individuals, dbSNP129, or the 1000 Genomes database.
The c.545A>G mutation that was detected in a family of
Israeli origin was found to be heterozygous in 2 out of 91
ethnically matched control individuals of Druze origin;
this finding is in line with previous carrier-frequencyred) the ciliary markers GT335 (antipolyglutamylated tubulin)
(B), antiacetylated a-tubulin (C), and anti-g-tubulin (D) revealed
that endogenous C8orf37 localizes to the base of the primary cilia.
Nuclei were stained with DAPI (in blue). Insets show selected
magnifications.
(E–G) Immunohistochemical staining in mouse retinal sections
(P30). The most intense labeling for C8orf37 (in green) was noted
at the base of the photoreceptor connecting cilia which partially
colocalized with (in red) the connecting cilium markers GT335
(antipolyglutamylated tubulin) (E), antiacetylated a-tubulin (F),
and anti-g-tubulin (G). C8orf37 also stains structures that extend
from the base of the cilium toward the inner segments, suggestive
of ciliary rootlets. Abbreviations are as follows: CC, connecting
cilia; IS, photoreceptor inner segments; and OS, photoreceptor
outer segments. The scale bars represent the following: (B–D),
20 mm and (E–G), 10 mm.
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Table 1. Summary of the Clinical Data of Six Individuals with C8orf37-Associated Retinal Dystrophies
Family Person Gender
bAge of
Onset
Visual Acuitya
Ophthalmoscopy
Full-Field ERG
(ODS) Diagnosis
Homozygous
MutationOD OS
1 IV:1 M infancy LP LP Macular atrophy, bone
spicule pigmentations,
attenuated retinal vessels.
nonrecordable RP (with
early macular
involvement)
c.497T>A
(p.Leu166*)
2 V:1 F 17 CF CF Atrophy of the central
macula with gliosis.
Temporal pallor of optic
disc. Moderate attenuation
of retinal arterioles. Some
peripheral pigmentations.
nonrecordable CRD c.1562A>G
2 V:2 M 10 20/125 20/125 Severe atrophy of the
central macula with gliosis.
Temporal pallor of optic
disc. Mild attenuation
of retinal arterioles.
nonrecordable CRD c.1562A>G
3 IV:2 M infancy 20/250 20/400 Peripapillar atrophy and
temporal optic disc pallor,
central isolated macular
RPE atrophy, and pigment
clumping. Attenuation
of retinal vessels.
nonrecordable
cone pattern,
severe reduced
rod recording
CRD c.529C>T
(p.Arg177Trp)
3 IV:3 M infancy 20/60 20/400 Central isolated macular
atrophy. Attenuation of
retinal vessels. No pigment
clumping associated
with the retinal dystrophy.
nonrecordable
cone pattern,
severe reduced
rod recording
CRD c.529C>T
(p.Arg177Trp)
4 IV:1 F 18 HM HM Waxy optic disc;
grayish atrophic changes
in maculas with
pigmentation. Bone
spicule-like pigmentation
and heavy pigment
in mid-periphery.
nonrecordable RP (with
early macular
involvement)
c.545A>G
(p.Gln182Arg)
Abbreviations are as follows: CF, counting fingers; CRD, cone-rod dystrophy; F, female; HM, hand movements; LP, light perception; M, male; OD, right eye; OS,
left eye; ODS, both eyes; and RP, retinitis pigmentosa.
a Fraction measured at 20 feet.
b Age at which the affected individuals of families 2 and 4 first noticed visual abnormalities; retinal abnormalities could have been present earlier.data reported for other mutations that were identified in
this population.23 The splice mutation c.1562A>G
affects one of two canonical nucleotides of the 30 splice
site and hence potentially leads to the skipping of exon
2, introducing a frameshift and a premature truncation
of the protein. Alignment of the C8orf37 amino-acid
sequences of various orthologs showed that the substituted
amino acids, i.e., arginine at position 177 and glutamine at
position 182, are highly conserved (Figure 1B). Gln-182 is
fully conserved up to Chlamydomonas and Phytophtora,
whereas Arg-177 is conserved up to sea urchins. PolyPhen
predicted that p.Arg177Trp is probably damaging, and
SIFT analysis revealed that it is not tolerated. PolyPhen
predicted that p.Gln182Arg is probably damaging, and
SIFT analysis revealed that it is tolerated.
The clinical characteristics of six individuals with
C8orf37 variants are summarized in Table 1. The age of
onset varied from infancy to the end of the second decade.
All affected individuals showed early involvement of the
macula, resulting in a loss of central vision at an early
age. Visual acuity in these individuals did not exceed 20/
60 and was as low as light perception in one individual.106 The American Journal of Human Genetics 90, 102–109, January 1Figure 4 shows a representative fundus image of V:2 of
family 2. It shows atrophy with a beaten-bronze aspect at
the center of the macula. The optic disc shows temporal
pallor, and there is a gliosis over the posterior pole. The
retinal arterioles are mildly attenuated. The optical coher-
ence tomography of this person shows a section of the
central retina that includes the fovea; the retina is atrophic
and much thinner than a normal retina.
The retinal phenotypes of four of the affected individ-
uals (V:1 and V:2 from family 2, IV:2 and IV:3 from family
3) were classified as CRD in view of the initial symptoms,
including photophobia and vision loss, ophthalmoscopic
abnormalities that involved the macula rather than the
periphery, and a cone pattern that was more reduced
than the rod pattern on the ERG in IV:2 and IV:3. In the
remaining four affected individuals, the deterioration of
the rod and cone systems appeared to occur simulta-
neously. Besides a loss of visual acuity, these individuals
also experienced night blindness in the early stage of their
disease. Whether the photoreceptor dystrophy in these
persons should be classified as CRD or rather as RP with
early macular involvement seems largely academic.3, 2012
Figure 4. Fundus Photograph and Optical Coherence Tomog-
raphy of the Left Eye of Individual V:2 of Family 2 at age 27
The upper panel of the fundus photograph shows atrophy with
a beaten-bronze aspect at the center of the macula. The optic
disc shows temporal pallor, and there is a gliosis over the posterior
pole. The retinal arterioles are mildly attenuated. The optical
coherence tomography in the lower panel shows a section of the
central retina that includes the fovea; the retina is atrophic and
much thinner than a normal retina.However, the phenotype in these individuals is more
severe than that of the four individuals with classic CRD,
considering the greater amount of vision loss and the
retinal abnormalities that spread into the far periphery.
Interestingly, two siblings (V:1 and V:2 from family 2)
also demonstrated a postaxial polydactyly at birth; they
each had an extra finger or toe on the right hand or foot,
respectively. Given that polydactyly is one of the features
of Bardet-Biedl syndrome (BBS [MIM 20900])24 (a cilio-
pathy that includes retinal dystrophy), it is unlikely that
this is a coincidental finding. Therefore,C8orf37mutations
might also contribute to extraocular abnormalities.
In this study, one nonsense, one splice-site, and two
missense mutations were identified in 4 of 15 families
with conspicuously large homozygous regions encompass-
ing C8orf37, two of which (p.Leu166* and c.1562A>G)
have an unequivocal pathogenic effect. The two missense
mutations (p.Arg177Trp and p.Gln182Arg) have been
subjected to in silico prediction analysis, which suggested
a pathogenic effect. Further functional studies are war-
ranted to confirm an impact of these missense mutations
on the function of C8orf37.
On the basis of the data presented above, it is difficult
to deduce a genotype-phenotype correlation. The individ-
uals with CRD and postaxial polydactyly from family
2 carry a splice-site mutation that most likely results in
the skipping of exon 2, yielding a frameshift and a trunca-
tion of the 154 carboxy-terminal amino acids. Moreover,
nonsense-mediated decay (NMD) could reduce the
amount of mutant RNA, effectively resulting in a null
allele. On the other hand, the p.Leu166* mutation identi-The Americfied in family 1 resides in exon 6, the last exon of C8orf37,
and thereby is not predicted to give rise to NMD. In theory,
only the 42 carboxy-terminal amino acids would be trun-
cated, which could result in a partially functional protein.
The precise effect of the missense mutations p.Arg177Trp
and p.Gln182Arg on the function of the C8orf37 protein
in families 3 and 4 cannot be predicted.
Given the extraocular clinical features of the siblings in
family 2, one could argue that they are the most severely
affected. This, however, is not the case for their retinal
phenotypes because the age of onset of retinal disease in
these individuals was in their teens (that of affected indi-
viduals from families 1 and 3 was in infancy). Postaxial
polydactyly is one of the cardinal clinical features of
BBS.24 To date, 15 genes have been associated with BBS
(RetNet),25 but DNA variants in BBS1 (MIM 209901)25,26
(A.E.-C., A.I.d.H., F.P.M.C., unpublished data), ARL6
(MIM 608845),27 BBS12 (MIM 610683),28 CEP290 (MIM
610142),29,30 and TTC8 (MIM 608132)31 have also been
associated with mild BBS or nonsyndromic retinal dystro-
phies. Therefore, it is very possible that C8orf37 is also
implicated in full-blown BBS or in other ciliopathies. In
view of the recent identification of a genetic modifier
that was enriched in ciliopathies with an ocular pheno-
type,32 it is possible that the affected persons in family 2
carry a genetic modifier that, together with the C8orf37
variants, influenced hand and foot development.
In conclusion, we have identified mutations in a ciliary-
expressed gene, C8orf37, and have found that these muta-
tions are associated with arCRD and arRP with early
macular involvement. Large-scale mutation analysis in
the future will reveal the pathologic burden of C8orf37
mutations in these diseases.Supplemental Data
Supplemental Data include one figure and can be found with this
article online at http://www.cell.com/AJHG/.Acknowledgments
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